Accurate delineation of targets and organs at risk for radiation therapy planning (RTP) remains a challenge due to the lack of soft tissue contrast in computed tomography (CT), the standard of care imaging for RTP. Radiation Oncology has addressed this limitation by registering magnetic resonance images (MRI) to CT datasets to take advantage of the superior soft tissue contrast afforded by MRI. MRI brings considerable value to RTP by improving delineation accuracy which, in turn, has enabled dose escalation to improve local control while maintaining or reducing normal tissue toxicities. However, the current integration of MRI as an adjunct to CT has significant drawbacks as it requires image registration and contour transfer between datasets. This process introduces systematic geometric uncertainties that persist throughout treatment and may compromise tumor control. Thus, we propose to translate MR-only RTP into clinical use, with the ultimate goal of improving patient outcomes accomplished via improved treatment plan design. MR-only RTP will eliminate redundant CT scans (reducing dose, patient time, and costs), streamline clinical efficiency, entirely circumvent registration uncertainties, and fully exploit the benefits of MRI for high-precision RTP. Yet, MRI is not routinely used alone for RTP, largely due to its known spatial distortions, lack of electron density, and inability to segment the bone needed for online image guidance and electron density mapping for dose calculation. The central hypothesis is that the innovative technologies that our multi-disciplinary academic/industrial (Henry Ford Health System/Philips Healthcare) collaboration develop will yield geometrically accurate patient models built from MRI data across several platforms/field strengths with CT-equivalent densities that can be used in confidence throughout the entire RTP workflow.
In Aim 1, we will perform geometric distortion corrections, determine distortion variability with changing anatomy, benchmark the results in a novel modular phantom, and develop an image processing toolkit.
In Aim 2, we will fully automate MR image segmentation in the brain and male/female pelvis to yield accurate synthetic CT patient models derived from novel MRI sequences, including provisions for metal implants, and benchmark the results in phantom.
In Aim 3, we will conduct end-to-end testing to characterize the uncertainties in the MR-only RTP workflow. We will perform a virtual clinical trial of MR-only RTP for brain and male/female pelvis and compare to the standard of care. Final translation will include developing physician-physicist practice guidelines, end-user validation of all translational steps, and dissemination of image processing tools into the Radiation Oncology community. This research will systematically address the major challenges limiting MR-only RTP and lay the groundwork for multi-institutional clinical trials across MRI platforms. It will support future work related to MR-guided RT, functional MRI for biologically adaptive RT, and focal RT to areas of high tumor burden.

Public Health Relevance

Magnetic resonance imaging (MRI) offers excellent soft tissue contrast and can help physicians resolve tumor and critical organ boundaries to ensure proper targeting of radiation therapy beams. The use of MRI as the primary dataset for treatment planning, which may improve planning accuracy, is largely limited by the inherent distortions and lack of density information in the MR images. The goal of this project is to develop, optimize, validate, and translate technology to correct for MRI image distortions, generate accurate anatomical models of the patient, and measure the overall uncertainty when MRI is used as the primary dataset for a virtual patient population.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA204189-01A1
Application #
9193976
Study Section
Special Emphasis Panel (ZRG1-SBIB-D (57)R)
Program Officer
Baker, Houston
Project Start
2016-07-01
Project End
2021-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
1
Fiscal Year
2016
Total Cost
$350,943
Indirect Cost
$76,367
Name
Henry Ford Health System
Department
Type
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Morris, Eric D; Kim, Joshua P; Klahr, Paul et al. (2018) Impact of a novel exponential weighted 4DCT reconstruction algorithm. J Appl Clin Med Phys 19:217-225
Xi, Jinxiang; Wang, Zhaoxuan; Talaat, Khaled et al. (2018) Numerical study of dynamic glottis and tidal breathing on respiratory sounds in a human upper airway model. Sleep Breath 22:463-479
Owrangi, Amir M; Greer, Peter B; Glide-Hurst, Carri K (2018) MRI-only treatment planning: benefits and challenges. Phys Med Biol 63:05TR01
Emami, Hajar; Dong, Ming; Nejad-Davarani, Siamak P et al. (2018) Generating synthetic CTs from magnetic resonance images using generative adversarial networks. Med Phys :
Wen, Ning; Kim, Joshua; Doemer, Anthony et al. (2018) Evaluation of a magnetic resonance guided linear accelerator for stereotactic radiosurgery treatment. Radiother Oncol 127:460-466
Morris, Eric D; Price, Ryan G; Kim, Joshua et al. (2018) Using synthetic CT for partial brain radiation therapy: Impact on image guidance. Pract Radiat Oncol 8:342-350
Ghanem, Ahmed I; Glide-Hurst, Carri; Siddiqui, M Salim et al. (2018) Retroperitoneal Metastasis Abutting Small Bowel: A Novel Magnetic Resonance-Guided Radiation Approach. Cureus 10:e2412
Price, Ryan G; Knight, Robert A; Hwang, Ken-Pin et al. (2017) Optimization of a novel large field of view distortion phantom for MR-only treatment planning. J Appl Clin Med Phys 18:51-61
Walker, Amy; Metcalfe, Peter; Liney, Gary et al. (2016) MRI geometric distortion: Impact on tangential whole-breast IMRT. J Appl Clin Med Phys 17:7-19
Price, Ryan G; Kim, Joshua P; Zheng, Weili et al. (2016) Image Guided Radiation Therapy Using Synthetic Computed Tomography Images in Brain Cancer. Int J Radiat Oncol Biol Phys 95:1281-9